Correction to “Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition”

Correction to “Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition”

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS applied materials & interfaces 2022-04, Vol.14 (16), p.19077-19077
Hauptverfasser: Cheng, Furong, Pan, Qingqing, Gao, Wenxia, Pu, Yuji, Luo, Kui, He, Bin
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 19077
container_issue 16
container_start_page 19077
container_title ACS applied materials & interfaces
container_volume 14
creator Cheng, Furong
Pan, Qingqing
Gao, Wenxia
Pu, Yuji
Luo, Kui
He, Bin
description
doi_str_mv 10.1021/acsami.2c04966
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2652028357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2652028357</sourcerecordid><originalsourceid>FETCH-LOGICAL-a2156-e6839e06541b7331204f6d42a0f6bba3b196fd480dfa7d77e67197a27df29f263</originalsourceid><addsrcrecordid>eNp1kctu1DAUhi0Eohe6ZYm8REgZfIszWVbToa00FVKh68iOj2dcJfZgOy3Z9UHgCXirPglpZ-iOlY_k7_-OrR-h95TMKGH0s2qT6t2MtUTUUr5Ch7QWopizkr1-mYU4QEcp3RIiOSPlW3TAS8FFXctD9GcRYoQ2u-BxDvjx4dc13EFMzq_xYgN9yBuIajvia0guZeVbwHrECn8bPcT1iDXkewCPV2MKKfSqw9uL4nQS3qkMBl-5HNpN8Ca66eosDmt8Bp2bVkwSb_AydiE773RxBcY9R56hpbXd8BNf-o3T7ul1jw-_36E3VnUJTvbnMbr5svy-uChWX88vF6erQjFaygLknNdAZCmorjinjAgrjWCKWKm14prW0hoxJ8aqylQVyIrWlWKVsay2TPJj9HHn3cbwY4CUm96lFrpOeQhDapgsGWFzXlYTOtuhbQwpRbDNNrpexbGhpHkqqNkV1OwLmgIf9u5B92Be8H-NTMCnHTAFm9swRD999X-2v1vAoCE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2652028357</pqid></control><display><type>article</type><title>Correction to “Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition”</title><source>ACS Publications</source><creator>Cheng, Furong ; Pan, Qingqing ; Gao, Wenxia ; Pu, Yuji ; Luo, Kui ; He, Bin</creator><creatorcontrib>Cheng, Furong ; Pan, Qingqing ; Gao, Wenxia ; Pu, Yuji ; Luo, Kui ; He, Bin</creatorcontrib><identifier>ISSN: 1944-8244</identifier><identifier>EISSN: 1944-8252</identifier><identifier>DOI: 10.1021/acsami.2c04966</identifier><identifier>PMID: 35434996</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>ACS applied materials &amp; interfaces, 2022-04, Vol.14 (16), p.19077-19077</ispartof><rights>2022 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a2156-e6839e06541b7331204f6d42a0f6bba3b196fd480dfa7d77e67197a27df29f263</citedby><orcidid>0000-0002-0939-9869 ; 0000-0002-3536-1485 ; 0000-0002-4465-0262 ; 0000-0002-3373-9827</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsami.2c04966$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsami.2c04966$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,777,781,2752,27057,27905,27906,56719,56769</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35434996$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, Furong</creatorcontrib><creatorcontrib>Pan, Qingqing</creatorcontrib><creatorcontrib>Gao, Wenxia</creatorcontrib><creatorcontrib>Pu, Yuji</creatorcontrib><creatorcontrib>Luo, Kui</creatorcontrib><creatorcontrib>He, Bin</creatorcontrib><title>Correction to “Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition”</title><title>ACS applied materials &amp; interfaces</title><addtitle>ACS Appl. Mater. Interfaces</addtitle><issn>1944-8244</issn><issn>1944-8252</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kctu1DAUhi0Eohe6ZYm8REgZfIszWVbToa00FVKh68iOj2dcJfZgOy3Z9UHgCXirPglpZ-iOlY_k7_-OrR-h95TMKGH0s2qT6t2MtUTUUr5Ch7QWopizkr1-mYU4QEcp3RIiOSPlW3TAS8FFXctD9GcRYoQ2u-BxDvjx4dc13EFMzq_xYgN9yBuIajvia0guZeVbwHrECn8bPcT1iDXkewCPV2MKKfSqw9uL4nQS3qkMBl-5HNpN8Ca66eosDmt8Bp2bVkwSb_AydiE773RxBcY9R56hpbXd8BNf-o3T7ul1jw-_36E3VnUJTvbnMbr5svy-uChWX88vF6erQjFaygLknNdAZCmorjinjAgrjWCKWKm14prW0hoxJ8aqylQVyIrWlWKVsay2TPJj9HHn3cbwY4CUm96lFrpOeQhDapgsGWFzXlYTOtuhbQwpRbDNNrpexbGhpHkqqNkV1OwLmgIf9u5B92Be8H-NTMCnHTAFm9swRD999X-2v1vAoCE</recordid><startdate>20220427</startdate><enddate>20220427</enddate><creator>Cheng, Furong</creator><creator>Pan, Qingqing</creator><creator>Gao, Wenxia</creator><creator>Pu, Yuji</creator><creator>Luo, Kui</creator><creator>He, Bin</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0939-9869</orcidid><orcidid>https://orcid.org/0000-0002-3536-1485</orcidid><orcidid>https://orcid.org/0000-0002-4465-0262</orcidid><orcidid>https://orcid.org/0000-0002-3373-9827</orcidid></search><sort><creationdate>20220427</creationdate><title>Correction to “Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition”</title><author>Cheng, Furong ; Pan, Qingqing ; Gao, Wenxia ; Pu, Yuji ; Luo, Kui ; He, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a2156-e6839e06541b7331204f6d42a0f6bba3b196fd480dfa7d77e67197a27df29f263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Furong</creatorcontrib><creatorcontrib>Pan, Qingqing</creatorcontrib><creatorcontrib>Gao, Wenxia</creatorcontrib><creatorcontrib>Pu, Yuji</creatorcontrib><creatorcontrib>Luo, Kui</creatorcontrib><creatorcontrib>He, Bin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ACS applied materials &amp; interfaces</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Furong</au><au>Pan, Qingqing</au><au>Gao, Wenxia</au><au>Pu, Yuji</au><au>Luo, Kui</au><au>He, Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to “Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition”</atitle><jtitle>ACS applied materials &amp; interfaces</jtitle><addtitle>ACS Appl. Mater. Interfaces</addtitle><date>2022-04-27</date><risdate>2022</risdate><volume>14</volume><issue>16</issue><spage>19077</spage><epage>19077</epage><pages>19077-19077</pages><issn>1944-8244</issn><eissn>1944-8252</eissn><cop>United States</cop><pub>American Chemical Society</pub><pmid>35434996</pmid><doi>10.1021/acsami.2c04966</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0939-9869</orcidid><orcidid>https://orcid.org/0000-0002-3536-1485</orcidid><orcidid>https://orcid.org/0000-0002-4465-0262</orcidid><orcidid>https://orcid.org/0000-0002-3373-9827</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1944-8244
ispartof ACS applied materials & interfaces, 2022-04, Vol.14 (16), p.19077-19077
issn 1944-8244
1944-8252
language eng
recordid cdi_proquest_miscellaneous_2652028357
source ACS Publications
title Correction to “Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition”
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T21%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to%20%E2%80%9CReversing%20Chemotherapy%20Resistance%20by%20a%20Synergy%20between%20Lysosomal%20pH-Activated%20Mitochondrial%20Drug%20Delivery%20and%20Erlotinib-Mediated%20Drug%20Efflux%20Inhibition%E2%80%9D&rft.jtitle=ACS%20applied%20materials%20&%20interfaces&rft.au=Cheng,%20Furong&rft.date=2022-04-27&rft.volume=14&rft.issue=16&rft.spage=19077&rft.epage=19077&rft.pages=19077-19077&rft.issn=1944-8244&rft.eissn=1944-8252&rft_id=info:doi/10.1021/acsami.2c04966&rft_dat=%3Cproquest_cross%3E2652028357%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2652028357&rft_id=info:pmid/35434996&rfr_iscdi=true